<p></p><p><span>Fatigue is a major symptom in patients with multiple sclerosis (pwMS) and is mainly responsible for unemployment, early retirement but also social withdrawal.ย This book combines reporting of actually existing scientific knowledge with guidance for clinical practice. As such the book
Fatigue in Multiple Sclerosis: Background, Clinic, Diagnostic, Therapy
โ Scribed by Iris-Katharina Penner (editor)
- Publisher
- Springer
- Year
- 2023
- Tongue
- English
- Leaves
- 208
- Edition
- 1st ed. 2023
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Fatigue is a major symptom in patients with multiple sclerosis (pwMS) and is mainly responsible for unemployment, early retirement but also social withdrawal.ย This book combines reporting of actually existing scientific knowledge with guidance for clinical practice. As such the book helps health care professionals in all countries to better understand fatigue symptoms but also to help patients to better cope with them.ย
ย
๐ SIMILAR VOLUMES
<b>Multiple Sclerosis: a complex disease requiring sophisticated management <br /></b>Multiple Sclerosis poses labyrinthine challenges. There is no blood test to rely on for diagnosis; clinical acumen is essential. Yet an effective diagnosis only takes you part of the way: treatment offers further e
This practical guide for physicians and other health care professionals discusses the impact of fatigue on the individual with MS, the potential etiologies underlying MS-related fatigue, its work up and diagnosis, and pharmacologic and nonpharmacologic management strategies. <P>Fatigue is perhap
Managing multiple sclerosis, with all the associated problems of a progressive chronic disease, requires special knowledge on the part of the clinician. From which drugs to prescribe for an acute attack, to the use of new drugs available to help control the disease process, to managing the myriad of
This reference presents cutting-edge basic and clinical research on all forms of interferon (IFN) involvement in the management of multiple sclerosis (MS)-detailing topics from IFN-receptor molecular interactions to synergy and interference with other agents such as cytotoxic drugs and chemotherapy.